Is Elmiron (pentosan polysulfate sodium) still sold in the US?
Yes. Elmiron is still on the market and is sold by its manufacturer as a prescription medicine for interstitial cystitis/bladder pain syndrome. [1]
Why do people say Elmiron might be “pulled” or “not available”?
Much of the confusion comes from safety concerns and related regulatory and manufacturer actions, plus how often pharmacies can fill prescriptions. In practice, “on the market” can still mean prescriptions are available, even if access becomes harder or slower due to restrictions, supply issues, or prescriber decisions. (The question is whether it is marketed/dispensed, not whether it is commonly prescribed.)
What safety concerns are linked to current use?
Elmiron has been associated with eye toxicity (including pigmentary maculopathy) in patient reports and regulatory communications. That risk drives many patients and clinicians to reconsider use, but it does not automatically remove the drug from sale. [1]
What should patients do if they can’t get it or are worried about continuing?
Patients should contact their prescribing clinician or pharmacist to confirm current availability and discuss alternatives and monitoring plans. If the concern is eyesight-related, clinicians typically advise eye evaluation and risk/benefit reassessment rather than abrupt self-discontinuation.
Can other treatments replace Elmiron?
For interstitial cystitis/bladder pain syndrome, clinicians may use other oral therapies, bladder-directed treatments, physical therapy, and other approaches depending on symptoms and medical history. The best substitution depends on the individual case and should be decided with a specialist.
Sources
1